Ask AI
S. 3248

United States Anti-Doping Agency Reauthorization Act of 2020

United States Anti-Doping Agency Reauthorization Act of 2020

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.

USADA shall

  • serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic and Paralympic Committee,
  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within U.S. jurisdiction, and
  • be recognized worldwide as the independent national anti-doping organization for the United States.

Any administrative action taken by USADA to enforce a USADA policy, procedure, or requirement against a person with respect to a violation of federal law shall be carried out in a manner that provides due process protection to the person.

The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Held at the desk.

Sen. Moran, Jerry [R-KS](R-KS)Sponsor
1 cosponsor1 D
1cosponsors1committees13actions1amendments1related bills14subjects
  1. FloorH15000

    Held at the desk.

  2. FloorH14000

    Received in the House.

  3. Floor

    Message on Senate action sent to the House.

  4. Floor

    Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)

  5. Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.

  6. Floor

    The committee amendments withdrawn by Unanimous Consent. (CR S7641)

  7. Floor

    Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)

  8. Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.

  9. Committee

    Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.

    Commerce, Science, and Transportation Committee
  10. Committee14000

    Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.

    Commerce, Science, and Transportation Committee
  11. Committee

    Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.

    Commerce, Science, and Transportation Committee
  12. IntroReferral

    Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Commerce, Science, and Transportation Committee
  13. IntroReferral10000

    Introduced in Senate

Dec 17, 202055

United States Anti-Doping Agency Reauthorization Act of 2020

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.

USADA shall

  • serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic and Paralympic Committee,
  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within U.S. jurisdiction, and
  • be recognized worldwide as the independent national anti-doping organization for the United States.

Any administrative action taken by USADA to enforce a USADA policy, procedure, or requirement against a person with respect to a violation of federal law shall be carried out in a manner that provides due process protection to the person.

The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Nov 17, 202025

United States Anti-Doping Agency Reauthorization Act of 2020

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.

The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

USADA must submit to Congress a report that (1) assesses its capacity to implement an equine anti-doping and medication control program; and (2) includes recommendations concerning best practices for the successful implementation of such a program in the United States and recommendations developed in consultation with the National Veterinary Services Laboratories regarding the appropriate technical standards and best practices.

Feb 3, 2020

United States Anti-Doping Agency Reauthorization Act of 2020

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.

The bill also directs (1) USADA to promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

United States Anti-Doping Agency Reauthorization Act of 2020 — Informed